Amalgamated Bank’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,177
| Closed | -$111K | – | 3329 |
|
|
2022
Q1 | $111K | Sell |
27,177
-2,293
| -8% | -$8.32K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $105K | Sell |
29,470
-434
| -1% | -$1.52K | ﹤0.01% | 2059 |
|
|
2021
Q3 | $109K | Sell |
29,904
-1,619
| -5% | -$6.55K | ﹤0.01% | 2074 |
|
|
2021
Q2 | $137K | Buy |
31,523
+5,989
| +23% | +$24.4K | ﹤0.01% | 2080 |
|
|
2021
Q1 | $105K | Hold |
25,534
| – | – | ﹤0.01% | 1551 |
|
|
2020
Q4 | $102K | Buy |
25,534
+120
| +0.5% | +$388 | ﹤0.01% | 1525 |
|
|
2020
Q3 | $69K | Sell |
25,414
-564
| -2% | -$1.56K | ﹤0.01% | 1437 |
|
|
2020
Q2 | $71K | Sell |
25,978
-2,574
| -9% | -$7.18K | ﹤0.01% | 1435 |
|
|
2020
Q1 | $67K | Buy |
28,552
+134
| +0.5% | +$456 | ﹤0.01% | 1538 |
|
|
2019
Q4 | $134K | Hold |
28,418
| – | – | ﹤0.01% | 1700 |
|
|
2019
Q3 | $95K | Sell |
28,418
-232
| -0.8% | -$764 | ﹤0.01% | 1661 |
|
|
2019
Q2 | $94K | Buy |
28,650
+6,129
| +27% | +$17.7K | ﹤0.01% | 1693 |
|
|
2019
Q1 | $68K | Buy |
22,521
+755
| +3% | +$2.45K | ﹤0.01% | 1626 |
|
|
2018
Q4 | $59K | Buy |
+21,766
| New | +$71.7K | ﹤0.01% | 1552 |
|
|
2018
Q3 | – | Sell |
-22,299
| Closed | -$58K | – | 1669 |
|
|
2018
Q2 | $58K | Buy |
22,299
+3,279
| +17% | +$8.16K | ﹤0.01% | 1692 |
|
|
2018
Q1 | $42K | Sell |
19,020
-183
| -1% | -$412 | ﹤0.01% | 1582 |
|
|
2017
Q4 | $38K | Buy |
19,203
+877
| +5% | +$1.91K | ﹤0.01% | 1629 |
|
|
2017
Q3 | $59K | Buy |
18,326
+898
| +5% | +$2.77K | ﹤0.01% | 1539 |
|
|
2017
Q2 | $56K | Buy |
+17,428
| New | +$49.4K | ﹤0.01% | 1538 |
|
|
2016
Q2 | – | Sell |
-16,323
| Closed | -$14K | – | 1407 |
|
|
2016
Q1 | $14K | Buy |
16,323
+1,444
| +10% | +$1.4K | ﹤0.01% | 1288 |
|
|
2015
Q4 | $18K | Sell |
14,879
-1,278
| -8% | -$1.78K | ﹤0.01% | 1198 |
|
|
2015
Q3 | $27K | Buy |
16,157
+147
| +0.9% | +$288 | ﹤0.01% | 1282 |
|
|
2015
Q2 | $33K | Buy |
16,010
+4,139
| +35% | +$10K | ﹤0.01% | 1346 |
|
|
2015
Q1 | $32K | Buy |
11,871
+466
| +4% | +$1.18K | ﹤0.01% | 923 |
|
|
2014
Q4 | $29K | Buy |
11,405
+19
| +0.2% | +$43 | ﹤0.01% | 847 |
|
|
2014
Q3 | $21K | Sell |
11,386
-4
| -0% | -$9 | ﹤0.01% | 839 |
|
|
2014
Q2 | $30K | Sell |
11,390
-259
| -2% | -$780 | ﹤0.01% | 867 |
|
|
2014
Q1 | $41K | Sell |
11,649
-54
| -0.5% | -$240 | 0.01% | 825 |
|
|
2013
Q4 | $52K | Buy |
+11,703
| New | +$47.7K | 0.01% | 820 |
|
Other funds holding ATRS
Amalgamated Bank's ATRS Position: Q2 2022 in Review
Amalgamated Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 27,177 shares — an estimated $111K sold.
Amalgamated Bank first reported a position in ATRS in Q4 2013 and held it in 29 quarters. The position peaked at $137K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Amalgamated Bank reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Amalgamated Bank sold 27,177 Antares Pharma, Inc. shares in Q2 2022, an estimated $111K.
- Amalgamated Bank first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 29 quarters.
- Amalgamated Bank's Antares Pharma, Inc. position peaked at $137K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.